This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
A new test based on gene sequencing may be used to assess a patient's suitability for treatment with CCR5 antagonists, a class of HIV antiretroviral...
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability...
On World Kidney Day, Quest Diagnostics, the world's leading provider of diagnostic information services, today announced its support of the updated...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Robert A. Hagemann, Senior Vice...